SIAIK
ABBV icon

Summit Investment Advisors, Inc.\KS’s AbbVie ABBV Stock Holding History

Summit Investment Advisors, Inc.\KS’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.66M Buy
6,329
+35
+0.6% +$8.97K 0.75% 23
2026
Q2 		$1.58M Buy
6,294
+17
+0.3% +$3.66K 0.72% 27
2026
Q1 		$1.37M Buy
6,277
+5
+0.1% +$1.11K 0.69% 28
2025
Q4 		$1.43M Buy
+6,272
New +$1.43M 0.77% 26

Other funds holding ABBV

Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Bahl & Gaynor
Bahl & Gaynor Cincinnati, Ohio $21B AUM 23.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Summit Investment Advisors, Inc.\KS's ABBV Position: Q3 2026 in Review

Summit Investment Advisors, Inc.\KS increased its AbbVie (ABBV) stake by 0.56% in Q3 2026, buying an estimated $8.97K and bringing the position to 6,329 shares worth $1.66M. The position accounts for 0.75% of the portfolio, ranked #23.

Summit Investment Advisors, Inc.\KS first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 2,565 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Summit Investment Advisors, Inc.\KS held 6,329 shares of AbbVie worth $1.66M as of Q3 2026.
  • Summit Investment Advisors, Inc.\KS bought 35 AbbVie shares in Q3 2026, an estimated $8.97K.
  • AbbVie made up 0.75% of Summit Investment Advisors, Inc.\KS's portfolio in Q3 2026, its #23 holding.
  • Summit Investment Advisors, Inc.\KS first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 2,565 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Summit Investment Advisors, Inc.\KS's 13F filing for Q3 2026, filed 5 Nov 2026.